• Resveratrol Inhibits EMT in Glioblastoma via Smad Signaling

  2026-05-05

  This study demonstrates that resveratrol suppresses epithelial-mesenchymal transition (EMT) and reduces stem cell-like properties in glioblastoma (GBM) by inhibiting TGF-β1-induced Smad-dependent signaling. These findings provide mechanistic insight into EMT regulation and highlight potential strategies for targeting GBM invasiveness.

• Adefovir-Induced Hypophosphatemic Osteochondrosis Mimicking

  2026-05-04

  This article analyzes a case report in which long-term adefovir therapy for hepatitis B virus led to hypophosphatemic osteochondrosis, closely imitating the clinical and imaging features of ankylosing spondylitis (AS). The findings underscore the importance of differential diagnosis in HBV-treated patients presenting with musculoskeletal symptoms, and illustrate the unique diagnostic pitfalls associated with nucleotide analog antivirals.

• Weight Loss Restores Gut Stretch-Induced Satiety in Obesity

  2026-05-04

  This study demonstrates that intestinal stretch acutely suppresses food intake and improves glucose tolerance, but these effects are impaired by obesity and restored following weight loss—either by diet or bariatric surgery. The findings clarify that mechanical gut signaling operates independently of classical incretin pathways and highlight new avenues for metabolic research.

• Melittin (SKU B6628): Reliable Solutions for Cell Assays

  2026-05-03

  Inconsistent assay results, pathway ambiguity, and workflow reproducibility remain central challenges in cell signaling and apoptosis research. This article leverages scenario-driven Q&A to illustrate how Melittin (SKU B6628) addresses these issues as a validated bioactive peptide tool. Researchers in cancer biology and signal transduction will find practical protocols, comparison insights, and evidence-based recommendations for Melittin’s use in preclinical workflows.

• Pentoxifylline: Phosphodiesterase Inhibitor for Inflammation

  2026-05-02

  Pentoxifylline stands out as a versatile phosphodiesterase inhibitor, enabling precision control of inflammatory and immune responses in both classic and advanced disease models. This article details actionable workflows, troubleshooting strategies, and the transformative value of Pentoxifylline in translational immunology and inflammation research.

• Canagliflozin: Mitochondrial Mechanisms and Translational Gu

  2026-05-01

  This thought-leadership article explores how Canagliflozin, a potent SGLT2 inhibitor, transforms translational research in diabetic kidney disease by bridging mitochondrial biology, rigorous experimental design, and workflow innovation. Grounded in recent evidence, with a focus on APExBIO's Canagliflozin (SKU A8333), it delivers actionable insights for researchers seeking to decode renal glucose reabsorption inhibition and metabolic modulation beyond glycemic endpoints.

• Carbon-Ion Radiotherapy Drives Ferroptosis via DHODH Suppres

  2026-05-01

  Wang and Cai (2025) reveal that carbon-ion radiotherapy (CIRT) suppresses gastric cancer by inducing ferroptosis and promoting M1 macrophage polarization through downregulation of DHODH. This study clarifies the molecular basis for CIRT’s efficacy and underscores the therapeutic potential of targeting DHODH in gastric cancer management.

• Adefovir (GS-0393) in HBV Antiviral Research: Mechanistic De

  2026-04-30

  Explore how Adefovir (GS-0393) enables precise mechanistic studies of hepatitis B virus (HBV) replication and transporter pharmacokinetics. This article delivers a uniquely rigorous analysis of Adefovir's biochemical selectivity, translational value, and assay decision-making for advanced HBV antiviral research.

• Technical Use of Angiotensin I/II (1-5) in RAS Research

  2026-04-30

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for researchers modeling blood pressure regulation and aldosterone signaling within the renin-angiotensin system. It is most suitable for cardiovascular and renal workflows, and should not be used in unrelated peptide signaling or mechanistic studies due to its specific solubility and pathway constraints.

• Milk-Derived Extracellular Vesicles in Intestinal Stem Cell

  2026-04-29

  This study establishes physiologically relevant intestinal stem cell–based models to investigate the uptake and functional effects of milk-derived extracellular vesicles (MEV). By uncovering region-specific uptake mechanisms and gene expression changes induced by MEV, the research advances our understanding of intestinal physiology and provides a robust platform for future membrane trafficking studies.

• A Multiendodermal Human Organ Atlas Benchmarks Organoid Fide

  2026-04-29

  Yu et al. (2021) present a single-cell transcriptome atlas spanning multiple human endoderm-derived organs and apply it to benchmark the fidelity of stem cell-derived intestinal organoids. This work enables precise evaluation and refinement of in vitro organoid models and illuminates key epithelial-mesenchymal interactions shaping human development.

• ddhCTP: Protocols and Innovations for RNA Virus Inhibition

  2026-04-28

  Leverage ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) to directly inhibit RNA virus replication in cell-based and in vitro assays. This guide delivers advanced workflow strategies, troubleshooting insights, and a breakdown of novel mechanisms from recent literature—empowering antiviral research with evidence-backed precision.

• Reserpine (SKU N1867): Technical Use and Lab Protocol Guidan

  2026-04-28

  Reserpine provides a standardized tool for neurotransmitter depletion, antihypertensive mechanism studies, and neuropharmacology research. It should only be used in research workflows and is not suitable for diagnostic or therapeutic applications. Proper storage, handling, and solubilization protocols are critical to maintain compound integrity and experimental reproducibility.

• LY294002: Precision PI3K/Akt/mTOR Inhibition in Cancer Resea

  2026-04-27

  LY294002, a potent and reversible PI3K/Akt/mTOR signaling inhibitor, enables mechanistic dissection of apoptosis, autophagy, and tumor progression in both in vitro and in vivo models. Discover how APExBIO’s LY294002 streamlines experimental workflows, empowers macrophage polarization studies, and offers robust troubleshooting strategies for reliable, reproducible results.

• Estradiol Benzoate: Applied Workflows for Estrogen Receptor

  2026-04-27

  Estradiol Benzoate stands out as a high-purity, validated estrogen receptor alpha agonist, powering robust hormone receptor binding assays and advanced signaling research. This guide delivers protocol enhancements, troubleshooting strategies, and practical insights for maximizing data quality and reproducibility in estrogen receptor-mediated studies.

15767 records 1/1052 page Next 12345 下5页 Last page